Literature DB >> 15025853

Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.

Audra L Stinchcomb1, Satyanarayana Valiveti, Dana C Hammell, Diana R Ramsey.   

Abstract

The purpose of this study was to quantify the in-vitro human skin transdermal flux of Delta8-tetrahydrocannabinol (Delta8-THC), cannabidiol (CBD) and cannabinol (CBN). These cannabinoids are of interest because they are likely candidates for transdermal combination therapy. Differential thermal analysis and in-vitro diffusion studies with human tissue were completed for the compounds. Heats of fusion, melting points and relative thermodynamic activities were determined for the crystalline compounds, CBD and CBN. Flux, permeability, tissue concentration and lag times were measured in the diffusion experiments. CBN had a lower heat of fusion and corresponding higher calculated relative thermodynamic activity than CBD. Ethanol concentrations of 30 to 33% significantly increased the transdermal flux of Delta8-THC and CBD. Tissue concentrations of Delta8-THC were significantly higher than for CBN. Lag times for CBD were significantly smaller than for CBN. The permeabilities of CBD and CBN were 10-fold higher than for Delta8-THC. Combinations of these cannabinoids with ethanol will be further studied in transdermal patch formulations in vitro and in vivo, as significant flux levels of all the drugs were obtained. CBD, the most polar of the three drugs, and other more polar cannabinoids will also be the focus of future drug design studies for improved transdermal delivery rates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025853     DOI: 10.1211/0022357022791

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  24 in total

1.  Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.

Authors:  Ketan Hippalgaonkar; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

Review 2.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

3.  Development of Water-Soluble Electrospun Fibers for the Oral Delivery of Cannabinoids.

Authors:  Eleftherios G Andriotis; Konstantina Chachlioutaki; Paraskevi Kyriaki Monou; Nikolaos Bouropoulos; Dimitrios Tzetzis; Panagiotis Barmpalexis; Ming-Wei Chang; Zeeshan Ahmad; Dimitrios G Fatouros
Journal:  AAPS PharmSciTech       Date:  2021-01-05       Impact factor: 3.246

4.  Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis.

Authors:  D C Hammell; L P Zhang; F Ma; S M Abshire; S L McIlwrath; A L Stinchcomb; K N Westlund
Journal:  Eur J Pain       Date:  2015-10-30       Impact factor: 3.931

5.  Determination of Cannabinoid Vapor Pressures to Aid in Vapor Phase Detection of Intoxication.

Authors:  Tara M Lovestead; Thomas J Bruno
Journal:  Forensic Chem       Date:  2017-06-27

6.  Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions.

Authors:  Marta Vázquez; Carlos García-Carnelli; Cecilia Maldonado; Pietro Fagiolino
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Safety and Sourcing of Topical Cannabinoids: Many Questions, Few Answers.

Authors:  Payal M Patel; Peter A Lio
Journal:  J Clin Aesthet Dermatol       Date:  2021-08-01

Review 8.  Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.

Authors:  Barbara Stella; Francesca Baratta; Carlo Della Pepa; Silvia Arpicco; Daniela Gastaldi; Franco Dosio
Journal:  Drugs       Date:  2021-09-04       Impact factor: 9.546

Review 9.  The pharmacokinetics and the pharmacodynamics of cannabinoids.

Authors:  Catherine J Lucas; Peter Galettis; Jennifer Schneider
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

Review 10.  The Interplay between the Immune and the Endocannabinoid Systems in Cancer.

Authors:  Mariantonia Braile; Simone Marcella; Gianni Marone; Maria Rosaria Galdiero; Gilda Varricchi; Stefania Loffredo
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.